Product
Radiolabeled EDG-5506
1 clinical trial
10 indications
Indication
Healthy VolunteerIndication
Muscular DystrophyIndication
Muscular DisordersIndication
AtrophicIndication
Muscular DiseasesIndication
Musculoskeletal DisordersIndication
Neuromuscular DisordersIndication
Nervous System DiseasesIndication
Genetic DiseasesIndication
InbornClinical trial
A Phase 1, Open-label Study in Healthy Male Subjects of the Absorption, Metabolism, Excretion, and Pharmacokinetics of EDG-5506 and an Absolute Bioavailability Study Using Radiolabeled EDG-5506Status: Completed, Estimated PCD: 2023-04-06